Fundraising Fox

4e Therapeutics

Austin, US · Founded 2019 · Delaware corporation

Founders & leadership

JP
Joseph PriceNamed on SEC filing
EP
Eric PriceNamed on SEC filing
TC
Thomas Craig BensonNamed on SEC filing
TP
Theodore PriceNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1.9M disclosed across 1 round · 2021

$1.9MraisedNov 2021 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph PriceDirector
  • Eric PriceDirector
  • Thomas Craig BensonExecutive Officer, Director
  • Theodore PriceDirector
Offering amount
$2M
Amount sold
$1.9M
First sale
Oct 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with 4e Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$5.6M
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$1.6M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

How much funding has 4e Therapeutics raised?
4e Therapeutics has disclosed $1.9M raised across 1 round.
Where is 4e Therapeutics headquartered?
4e Therapeutics is headquartered in Austin, US.